However, polymorphisms alter to predict the response to metastatic breast cancer chemotherapy [17] and tumor necrosis factor, α-induced protein 3 (TNFAIP3) gene mutation in oral squamous cell carcinoma [18]. This evidence concerns the gene TNFAIP3 and breast carcinoma.